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The data presented in this paper provide a description of demand for drug treatment
services in seven health boards, namely: the Midland, Mid-Western, North Eastern,
North Western, Southern, South Eastern and Western Health Boards. This paper will help
inform service planning and provision. 
The analysis presented in this paper is based on data reported to the National Drug
Treatment Reporting System. 
The main findings and their implications are: 
• The number of new and previously treated cases in the seven health boards (outside
the Eastern Regional Health Authority area) almost trebled between 1998 and 2002. 
• Both new and previously treated cases in the seven health board areas most
frequently reported that cannabis was their main problem drug between 1998 and
2002. The total number of cases reporting cannabis as their main problem drug
trebled, increasing from 409 in 1998 to 1,359 in 2002. The numbers reporting
problem opiate use almost trebled, from 184 in 1998 to 532 in 2002. Opiate use
was more common in the health board areas bordering the Eastern Regional Health
Authority area. Though small, the numbers reporting cocaine use increased
consistently, indicating the early years of an epidemic. The wide spectrum of
problem drugs reported indicates that treatment services need to cater for a number
of licit and illicit drugs used rather than focusing on one or two drugs. 
• Although there was a small decrease in the proportion of cases taking more than
one drug (polydrug use), from 84 per cent in 1998 to 77 per cent in 2002, it
remained a common practice and is associated with poorer treatment outcomes.
Polydrug use is an issue that needs to be addressed in a client’s treatment plan. 
• The number of cases who reported injecting more than doubled, from 148 in 1998
to 342 in 2002. Half of the injector cases had started injecting before they were 20
years old. Injectors have a higher risk of acquiring blood-borne viral infections and
experiencing overdose than non-injectors. This suggests that the drug treatment
services outside the ERHA require prevention and treatment interventions to deal
with blood-borne viruses (in particular HIV, hepatitis B, and hepatitis C) and drug
overdose (in particular opiate-related overdoses). 
• The proportion of cases under 18 years old increased by four per cent over the
reporting period and, as expected, was much higher for new cases than for those
previously treated. Those under 18 years old require different approaches to
treatment and it is important that this is recognised in service planning. 
• The low levels of educational achievement and employment among chronic
problem drug users emphasises the importance of close links between treatment
interventions and social and occupational reintegration programmes.
Summary
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Introduction
The National Drug Treatment Reporting System (NDTRS) is an epidemiological database on treated problem
drug use in Ireland. It was established in 1990 in the Greater Dublin Area and was extended in 1995 to cover
other areas of the country. The reporting system was originally developed in line with the Pompidou Group’s
Definitive Protocol (Hartnoll 1994) and subsequently refined in accordance with the Treatment Demand
Indicator Protocol (EMCDDA and Pompidou Group 2000). The NDTRS is co-ordinated by staff at the Drug
Misuse Research Division (DMRD) of the Health Research Board (HRB) on behalf of the Department of Health
and Children. 
Drug treatment data are viewed as an indirect indicator of drug misuse as well as a direct indicator of demand
for treatment services. These data are used at national and European levels to provide information on the
characteristics of clients entering treatment, and on patterns of drug misuse, such as types of drugs used and
consumption behaviours. They are ‘valuable from a public health perspective to assess needs, … and to plan and
evaluate services’ (EMCDDA 1998: 23). Information from the NDTRS is made available to service providers and
policy makers and is used to inform local and national drug policy and planning. For example, in 1996 NDTRS
data were used to identify a number of local areas with problematic heroin use (Ministerial Task Force 1996).
These areas were later designated as Local Drugs Task Force Areas and are continuing to provide strategic
responses to drug misuse in their communities. 
The monitoring role of the NDTRS is recognised by the Government in its document Building on Experience: National
Drugs Strategy 2001–2008. Data collection for the NDTRS is one of the actions identified and agreed by Government
for implementation by health boards:  ‘All treatment providers should co-operate in returning information on
problem drug use to the DMRD of the HRB’ (Department of Tourism, Sport and Recreation 2001: 118). 
• Incidence is a term used to describe the number of new cases of disease or events that develop among a
population during a specified time interval.  For example, in 2001, ten opiate users living in a specific
county sought treatment for the first time.  The incidence is the number of opiate cases divided by the
population living in the county (say 31,182 persons in this example) expressed per given number of the
population, i.e., per 100, per 1,000, per 10,000, etc.
–  The calculation in this case is as follows: (10/31,182) x 10,000, which gives an incidence rate of 3.2 per
10,000 of the specific county population in 2001.
• Prevalence is a term used to describe the proportion of people in a population who have a disease or
condition at a specific point or period in time.  For example, in 2001, ten opiate users living in a specific
county sought treatment for the first time, 20 opiate users returned to treatment in the year and five
opiate users continued in treatment from the previous year; in total there are 35 people treated for
problem opiate use in 2001.  The prevalence is the total number of cases (35) divided by the population
living in the county (31,182 persons) expressed per given number of the population, i.e., per 100, per
1,000, per 10,000, etc. 
– The calculation in this case is as follows: (35/31,182) x 10,000, which gives a prevalence rate of 11.2
per 10,000 of the specific county population in 2001.
• The median is the value at the mid-point in a sequence of numerical values ranged in ascending or
descending order. It is defined as the value above or below which half of the values lie. Unlike the mean
(average), the median is not influenced by extreme values (or outliers).  For example, in the case of five
drug users aged 22, 23, 24, 24 and 46 years respectively, the median (middle value) is 24 years, whereas
the mean is 27.8 years.  While both the median and the mean describe the central value of the data, the
median is more useful since the mean is influenced by the one older person in this example.
Glossary of terms
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Compliance with the NDTRS requires that one form be completed for each person who receives treatment for
problematic drug use at each treatment centre in a calendar year. Service providers at drug treatment centres
throughout Ireland collect data on each individual treated for drug misuse. At national level, staff at the DMRD
of the HRB compile anonymous, aggregated data. 
For the purpose of the NDTRS, treatment is broadly defined as ‘any activity which aims to ameliorate the
psychological, medical or social state of individuals who seek help for their drug problems’. Clients who attend
needle-exchange services are not included in this reporting system.  Up to 2004, clients who reported alcohol as
their main problem drug were not included in this reporting system. Treatment options include one or more of
the following: medication (detoxification, methadone reduction and substitution programmes), addiction
counselling, group therapy, psychotherapy and/or life skills training. Treatment is provided in both residential
and non-residential settings. In the seven health board areas, data returns to the NDTRS for clients attending
treatment services during 2002 were provided by 79 treatment services: 63 non-residential and 16 residential
(Table 1). 
The main elements of the reporting system are defined as follows: 
• All cases treated – describes individuals who receive treatment for problematic drug use at each treatment
centre in a calendar year, and includes both 
(a) Previously treated cases – describes individuals who were treated previously for problematic drug use
at any treatment centre and have returned to treatment in the reporting year, and also those
individuals continuing in treatment from the preceding calendar year; and
(b) New cases treated – describes individuals who have never been treated for problem drug use. 
In the case of the data for ‘previously treated cases’ there is a possibility of duplication in the database; for
example, where a person receives treatment at more than one centre. For those receiving methadone
maintenance or detoxification, this possibility is considered to be small since the introduction of the Misuse of
Drugs Regulations in 1998, whereby precautions are taken to ensure that methadone treatment is available from
one source only. 
As a result of small numbers in 1998 and a high rate (13%) of treatment status unknown, some of the
comparisons are limited to the time period 1999 to 2000.  
The data presented in this paper provide a description of demand for drug treatment services in seven health
boards, namely: the Midland, Mid-Western, North Eastern, North Western, Southern, South Eastern and Western
Health Boards. The total numbers treated in the seven health boards include cases resident the Eastern Regional
Health Authority and cases not resident in Ireland who sought treatment in one of the seven health boards
between 1998 and 2002. 
Methods
Analysis of treatment data
The analysis presented provides an overview of service provision for problem drug use, initial treatment
provided, main problem drugs, risk behaviours, and socio-demographic characteristics of cases.
Service provision
The total number of treatment outlets for problem drug use available in the seven health boards outside the
Eastern Regional Health Authority area and participating in the NDTRS increased between 1998 and 2002
(Table 1). The largest increase was in outpatient treatment services, while there was a small increase in the
number of residential treatment services. The number of general practitioners participating in the NDTRS was
very low. In 2002, there were 49 general practitioners prescribing methadone treatment outside the Eastern
Regional Health Authority area but only four of these provided returns to the NDTRS. There are no low-
threshold services providing low-dose methadone therapy outside Counties Dublin, Kildare and Wicklow. The
prison service does not participate in the NDTRS, although it does provide drug treatment services. 
Numbers treated
Overall, the number of new and previously treated cases in the seven health boards (outside the Eastern Regional
Health Authority area) and reported to the NDTRS trebled between 1998 and 2002 (Table 2). Each year, over
half of cases were treated for the first time during the period under review.
Table 2    Number (%) of cases* treated in the seven health board† areas by treatment status
reported to the NDTRS, 1998 to 2002
Treatment status 1998 1999 2000 2001 2002      
Number (%)
All cases 888 1063 1671 2098 2397  
Previously treated cases 306 (34.5) 441 (41.5) 618 (37.0) 787 (37.5) 917 (38.3)  
New cases 472 (53.2) 595 (56.0) 1013 (60.6) 1205 (57.4) 1341 (55.9)  
Status unknown 110 (12.4) 27 (2.5) 40 (2.4) 106 (5.1) 139 (5.8) 
* Numbers include cases living in the Eastern Regional Health Authority but treated in another health board area, and exclude cases
living in one of the seven health board areas but treated in the Eastern Regional Health Authority and recorded in the NDTRS.
† Midland Health Board, Mid-Western Health Board, North Eastern Health Board, North Western Health Board, Southern Health
Board, South Eastern Health Board and Western Health Board. 
Of the 8,117 cases treated in the seven health boards and reported to the NDTRS between 1998 and 2002, the
highest number of cases were treated in the Southern Health Board (2,164, 26%); followed closely by the South
Eastern Health Board (1,931, 24%) and the Mid-Western Health Board (1,655, 20%). The North Eastern Health
Board treated 1,109 (14%) cases during the period under review, while the Midland, North Western and
Western Health Boards treated smaller numbers of all cases, 646 (8%), 391 (5%) and 239 (3%) respectively. 
Table 3 presents a breakdown of the total number of cases reported to the NDTRS by health board where
treated between 1998 and 2002. In 2002, the number of cases treated in the North Eastern Health Board area
decreased by almost 14 per cent. According to staff at that health board, the reduction in numbers reported to
the NDTRS in 2002 was due to a reduction in returns to the reporting system rather than to an actual reduction
in the demand for services. Staff at the North Eastern Health Board’s Public Health Department have addressed
the reduction in returns to the NDTRS for the area for 2003.  
As a proportion of all cases treated in each of the seven health boards and reported to the NDTRS during the
reporting period, 40 per cent of cases treated in the Mid-Western Health Board lived in other health board areas,
while 16 per cent of cases treated in the South Eastern Health Board lived in other health board areas. This
observation is explained by the fact that there are residential treatment services located in these two health
boards that are used by individuals with problem drug use from all parts of the country. In the remaining health
boards, 2.5 per cent or less of the cases treated were living in health board areas other than the one in which
they were treated. 
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Table 1   Number and type of services providing treatment for problem drug use, and number of cases*
treated (in brackets) in the seven health board† areas and reported to the NDTRS, 1998 to 2002
Drug services 1998 1999 2000 2001 2002         
Outpatient 36 (598) 35 (762) 50 (1272) 60 (1339) 59 (1519)  
Residential 12 (290) 10 (293) 13 (395) 13 (745) 16 (872)  
Low threshold 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)  
General practitioner 0 (0) 5 (8) 3 (4) 5 (14) 4 (6)  
Prison 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)  
* Numbers include cases living in the Eastern Regional Health Authority but treated in another health board area, and exclude cases living in
one of the seven health board areas but treated in the Eastern Regional Health Authority and recorded in the NDTRS.
† Midland Health Board, Mid-Western Health Board, North Eastern Health Board, North Western Health Board, Southern Health Board, South
Eastern Health Board and Western Health Board. 
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Previously treated cases are an indicator of continued demand for treatment by chronic drug users in the seven
health board areas. From 1998 to 2002, the number of previously treated cases returning to or continuing in
treatment in one of the seven health boards increased each year for five of the health board areas (Table 3).
The number of previously treated cases in the North Eastern Health Board area decreased by 10 per cent in
2002 compared to 2001; the reason for this has been mentioned above. The number of previously treated
cases in the Mid-Western Health Board area decreased by 23 per cent between 2000 and 2002; the reason for
this is not clear. 
New cases are an indicator of new trends in treated problem drug use. From 1998 to 2002, the number of new
cases treated increased each year for five of the health board areas (Table 3). For the same reason given above,
the number of new cases treated in the North Eastern Health Board area decreased by 18 per cent in 2002
compared to 2001. The number of new cases treated in the Midland Health Board area fell by 31 per cent
between 2000 and 2002; the reason for this is not clear. Anecdotal reports suggest that there was not an
adequate number of methadone places for problem opiate users available in this health board area and the
reduction in numbers of new cases may indicate a significant delay in entering treatment. 
Table 3   Number of cases* treated in each health board by treatment status reported to the
NDTRS, 1998 to 2002
1998 1999 2000 2001 2002  
Health Board where treated Number (%)         
All cases 888 1063 1671 2098 2397  
Midland Health Board 85 (9.6) 128 (12.0)  150 (9.0) 123 (5.9) 160 (6.7)  
Mid-Western Health Board 200 (22.5) 281 (26.4) 327 (19.6) 423 (20.2) 424 (17.7)  
North Eastern Health Board 71 (8.0) 123 (11.6) 250 (15.0) 358 (17.1) 307 (12.8)  
North Western Health Board 45 (5.1) 39 (3.7) 77 (4.6) 99 (4.7) 131 (5.5)  
Southern Health Board 263 (29.6) 258 (24.3) 429 (25.7) 555 (26.5) 641 (26.7)  
South Eastern Health Board 216 (24.3) 212 (19.9) 424 (25.4) 474 (22.6) 605 (25.2)  
Western Health Board 8 (0.9) 22 (2.1) 14 (0.8) 66 (3.1) 129 (5.4)   
Previously treated cases 306 441 618  787  917   
Midland Health Board 45 (14.7) 47 (10.7)  55 (8.9) 58 (7.4) 83 (9.1)  
Mid-Western Health Board 63 (20.6) 148 (33.6) 142 (23.0) 138 (17.5) 110 (12.0)  
North Eastern Health Board 1 (0.3) 37 (8.4) 73 (11.8) 138 (17.5) 124 (13.5)  
North Western Health Board 14 (4.6) 13 (2.9) 15 (2.4) 27 (3.4) 58 (6.3)  
Southern Health Board 91 (29.7) 108 (24.5) 167 (27.0) 182 (23.1) 256 (27.9)  
South Eastern Health Board 86 (28.1) 79 (17.9) 165 (26.7) 217 (27.6) 236 (25.7)  
Western Health Board 6 (2.0) 9 (2.0) 1 (0.2) 27 (3.4) 50 (5.5)   
New cases  472 595  1013 1205 1341  
Midland Health Board 39 (8.3) 76 (12.8)  87 (8.6) 65 (5.4) 60 (4.5)  
Mid-Western Health Board 109 (23.1) 127 (21.3) 174 (17.2) 208 (17.3) 223 (16.6)  
North Eastern Health Board 0 (0.0) 78 (13.1) 171 (16.9) 202 (16.8) 166 (12.4)  
North Western Health Board 29 (6.1) 26 (4.4) 60 (5.9) 70 (5.8) 71 (5.3)  
Southern Health Board 169 (35.8) 148 (24.9) 262 (25.9) 368 (30.5) 380 (28.3)  
South Eastern Health Board 124 (26.3) 127 (21.3) 246 (24.3) 253 (21.0) 363 (27.1)  
Western Health Board 2 (0.4) 13 (2.2) 13 (1.3) 39 (3.2) 78 (5.8)   
Treatment status unknown 110 27 40 106 138        
* Numbers include cases living in the Eastern Regional Health Authority but treated in another health board area, and exclude cases living
in one of the seven health board areas but treated in the Eastern Regional Health Authority and recorded in the NDTRS.
Treatment provision
Given the complex nature of problems associated with drug misuse, it is recognised that there is no single
treatment modality for problem drug use. Consequently, a broad range of services covering treatment and
rehabilitation is provided throughout the country. A question ascertaining the type of treatment provided on
admission to treatment was introduced to the NDTRS form in 1999.  Of the 7,217 cases who received treatment
in the seven health board areas between 1999 and 2002 and were reported to the NDTRS, 7,086 had an initial
treatment recorded and 131 had no treatment recorded. Of the 7,086 cases for whom initial treatment was
documented, 89 per cent (6,314) received counselling or advice, 21 per cent (1,514) had medication-free therapy,
6 per cent (451) attended a social or occupational rehabilitation programme, 5 per cent (351) commenced
medically assisted detoxification and 4 per cent (300) commenced methadone maintenance at their first
treatment visit. Of the 7,086 cases for whom initial treatment was documented, 1,913 (27%) had more than one
type of initial treatment, therefore the total number of treatments is greater than the number of cases (7,086).
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Main problem drugs
Overall, cases treated in the seven health board areas most frequently reported that cannabis was their main
problem drug between 1998 and 2002 (Table 4). The number of cases reporting cannabis as their main problem
drug increased substantially, from 409 in 1998 to 1,359 in 2002. The same trend in cannabis use was noted for
both new and previously treated cases. The numbers reporting problem opiate use trebled during the same
period. The second most frequently reported main problem drug was ecstasy for new cases and opiates for
previously treated cases between 1998 and 2001. In 2002, the second most frequently reported main problem
drug was an opiate for both new and previously treated cases. The numbers reporting amphetamines as their
main problem drug decreased, while the numbers reporting cocaine, though small, increased consistently,
indicating the early years of an epidemic. The number of cases reporting benzodiazepines use also increased
during the period under review. 
Table 4   Main problem drug reported by cases* treated in the seven health board† areas by
treatment status and reported to the NDTRS, 1998 to 2002 
Main problem drug     1998    1999    2000    2001 2002   
Number (%)         
All cases 888 1063 1671 2098 2397  
Cannabis 409 (46.1) 559 (52.6) 959 (57.4) 1161 (55.3) 1359 (56.7)  
Opiates 184 (20.7) 225 (21.2) 288 (17.2) 447 (21.3) 532 (22.2)  
Ecstasy 145 (16.3) 156 (14.7) 254 (15.2) 271 (12.9) 245 (10.2)  
Amphetamines 45 (5.1) 42 (4.0) 28 (1.7) 19 (0.9) 28 (1.2)  
Benzodiazepines 37 (4.2) 22 (2.1) 42 (2.5) 51 (2.4) 63 (2.6)  
Cocaine 24 (2.7) 19 (1.8) 35 (2.1) 57 (2.7) 82 (3.4)  
Volatile Inhalants 18 (2.0) 24 (2.3) 30 (1.8) 37 (1.8) 43 (1.8)  
Other substances 26 (2.9) 16 (1.5) 35 (2.1) 55 (2.6) 45 (1.9)   
Previously treated cases 306 441 618 787 917  
Cannabis 116 (37.9) 186 (42.2) 315 (51.0) 367 (46.6) 438 (47.8)  
Opiates 78 (25.5) 148 (33.6) 165 (26.7) 256 (32.5) 279 (30.4)  
Ecstasy 45 (14.7) 49 (11.1) 67 (10.8) 85 (10.8) 85 (9.3)  
Benzodiazepines 20 (6.5) 14 (3.2) 22 (3.6) 24 (3.0) 45 (4.9)  
Amphetamines 16 (5.2) 18 (4.1) 11 (1.8) 14 (1.8) 15 (1.6)  
Cocaine 15 (4.9) 8 (1.8) 18 (2.9) 20 (2.5) 28 (3.1)  
Volatile inhalants 6 (2.0) 8 (1.8) 8 (1.3) 2 (0.3) 8 (0.9)  
Other substances 10 (3.3) 10 (2.3) 12 (1.9) 19 (2.4) 19 (2.1)   
New cases 472 595 1013 1205 1341  
Cannabis 251 (53.2) 364 (61.2) 623 (61.5) 742 (61.6) 862 (64.3)  
Ecstasy 90 (19.1) 102 (17.1) 181 (17.9) 180 (14.9) 156 (11.6)  
Opiates 71 (15.0) 70 (11.8) 113 (11.2) 157 (13.0) 195 (14.5)  
Amphetamines 21 (4.4) 21 (3.5) 17 (1.7) 5 (0.4) 13 (1.0)  
Benzodiazepines 12 (2.5) 8 (1.3) 19 (1.9) 25 (2.1) 18 (1.3)  
Volatile Inhalants 9 (1.9) 15 (2.5) 21 (2.1) 34 (2.8) 34 (2.5)  
Cocaine 6 (1.3) 10 (1.7) 16 (1.6) 30 (2.5) 43 (3.2)  
Other substances 12 (2.5) 5 (0.8) 23 (2.3) 32 (2.7) 20 (1.5)   
* Numbers include cases living in the Eastern Regional Health Authority but treated in another health board area, and exclude cases living in
one of the seven health board areas but treated in the Eastern Regional Health Authority and recorded in the NDTRS.
† Midland Health Board, Mid-Western Health Board, North Eastern Health Board, North Western Health Board, Southern Health Board, South
Eastern Health Board and Western Health Board. 
Although there was a small decrease in the proportion of cases taking more than one drug (polydrug use), from
84 per cent in 1998 to 77 per cent in 2002 (Table 5), it remained a common practice and is associated with
poorer treatment outcomes. Polydrug use is an issue that needs to be addressed in the client’s treatment plan. 
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Table 5   Use of more than one drug reported by cases* treated in the seven health board† areas
by treatment status and reported to the NDTRS, 1998 to 2002
Used more than one drug    1998    1999    2000    2001 2002   
Number (%)        
All cases 749 (84.3) 831 (78.2) 1360 (81.4) 1641 (78.2) 1849 (77.1)  
Previously treated cases 269 (87.9) 361 (81.9) 511 (82.7) 602 (76.5) 731 (79.7)  
New cases 401 (85.0) 448 (75.3) 819 (80.8) 961 (79.8) 1023 (76.3)  
Unknown 79 22 30 78 95         
* Numbers include cases living in the Eastern Regional Health Authority but treated in another health board area, and exclude cases living in
one of the seven health board areas but treated in the Eastern Regional Health Authority and recorded in the NDTRS.
† Midland Health Board, Mid-Western Health Board, North Eastern Health Board, North Western Health Board, Southern Health Board, South
Eastern Health Board and Western Health Board. 
Among the cases treated in the seven health board areas between 1998 and 2002 who reported use of a
second problem drug, alcohol, ecstasy and cannabis were the second problem drugs most frequently reported
(Table 6). The number of cases reporting either alcohol or ecstasy as their second problem drug increased
substantially during the period under review. The numbers reporting amphetamines as their second problem
drug decreased, while the numbers reporting benzodiazepines, cocaine and opiates increased. Benzodiazepines
and opiates as second problem drugs were more frequently reported by previously treated cases than by new
cases; cocaine as a second drug was more frequently reported by new cases than by previously treated cases.  
Table 6   Second problem drug reported by cases* treated in the seven health board† areas by
treatment status and reported to the NDTRS, 1998 to 2002
Second problem drug 1998    1999   2000    2001 2002   
Number (%)         
All cases 749 831 1360 1641 1848 
Ecstasy 190 (25.4) 244 (29.4) 406 (29.9) 484 (29.5) 474 (25.6)  
Cannabis 169 (22.6) 194 (23.3) 293 (21.5) 379 (23.1) 363 (19.6)  
Alcohol 127 (17.0) 138 (16.6) 306 (22.5) 410 (25.0) 620 (33.5)  
Amphetamines 118 (15.8) 112 (13.5) 111 (8.2) 70 (4.3) 87 (4.7)  
Opiates 45 (6.0) 25 (3.0) 56 (4.1) 53 (3.2) 62 (3.4)  
Cocaine 20 (2.7) 38 (4.6) 59 (4.3) 94 (5.7) 106 (5.7)  
Benzodiazepines 19 (2.5) 24 (2.9) 40 (2.9) 51 (3.1) 59 (3.2)  
Volatile inhalants 2 (0.3) 8 (1.0) 13 (1.0) 18 (1.1) 20 (1.1) 
Other substances 59 (7.9) 48 (5.8) 76 (5.6) 82 (5.0) 57 (3.1)  
Previously treated cases 269 361 511 602 731 
Cannabis 70 (26.0) 92 (25.5) 121 (23.7) 163 (27.1) 162 (22.2)  
Ecstasy 58 (21.6) 82 (22.7) 126 (24.7) 152 (25.2) 158 (21.6)  
Alcohol 41 (15.2) 56 (15.5) 102 (20.0) 131 (21.8) 228 (31.2)  
Amphetamines 33 (12.3) 38 (10.5) 42 (8.2) 23 (3.8) 31 (4.2)  
Opiates 19 (7.1) 19 (5.3) 28 (5.5) 35 (5.8) 40 (5.5)  
Benzodiazepines 14 (5.2) 15 (4.2) 25 (4.9) 34 (5.6) 44 (6.0)  
Cocaine 9 (3.3) 23 (6.4) 29 (5.7) 35 (5.8) 35 (4.8)  
Volatile inhalants 0 (0.0) 3 (0.8) 4 (0.8) 5 (0.8) 9 (1.2)  
Other substances 25 (9.3) 33 (9.1) 34 (6.7) 24 (4.0) 24 (3.3)  
New cases 401 448 819 961 1022  
Ecstasy 106 (26.4) 155 (34.6) 268 (32.7) 306 (31.8) 297 (29.1)  
Cannabis 86 (21.4) 98 (21.9) 166 (20.3) 200 (20.8) 181 (17.7)  
Alcohol 82 (20.4) 77 (17.2) 197 (24.1) 271 (28.2) 365 (35.7)  
Amphetamines 70 (17.5) 70 (15.6) 67 (8.2) 44 (4.6) 53 (5.2)  
Opiates 14 (3.5) 5 (1.1) 27 (3.3) 17 (1.8) 21 (2.1)  
Cocaine 9 (2.2) 15 (3.3) 30 (3.7) 50 (5.2) 62 (6.1)  
Benzodiazepines 4 (1.0) 8 (1.8) 13 (1.6) 15 (1.6) 14 (1.4)  
Volatile inhalants 2 (0.5) 5 (1.1) 9 (1.1) 13 (1.4) 10 (1.0)  
Other substances 28 (7.0) 15 (3.3) 42 (5.1) 45 (4.7) 19 (1.9)  
* Numbers include cases living in the Eastern Regional Health Authority but treated in another health board area, and exclude cases living in
one of the seven health board areas but treated in the Eastern Regional Health Authority and recorded in the NDTRS.
† Midland Health Board, Mid-Western Health Board, North Eastern Health Board, North Western Health Board, Southern Health Board, South
Eastern Health Board and Western Health Board. 
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Risk behaviours
The number of cases who reported injecting more than doubled, increasing from 148 in 1998 to 342 in 2002
(Table 7). This increase was noted among both new and previously treated cases. Fifty per cent of cases had
started injecting before they were 20 years old. Over two-fifths of injector cases had shared injecting equipment.
A higher proportion of previously treated injector cases shared injecting equipment than the new cases who
injected. Injectors have a higher risk of acquiring blood-borne viral infections and experiencing overdose than
non-injectors. This suggests that the drug treatment services require prevention and treatment interventions to
deal with blood-borne viruses (in particular HIV, hepatitis B, and hepatitis C) and drug overdose (in particular
opiate-related overdoses). 
Table 7   Risk behaviours reported by cases* treated in the seven health board† areas by
treatment status and reported to the NDTRS, 1998 to 2002
Injecting and sharing status 1998 1999 2000 2001 2002         
All cases injector status known 766 1006 1606 2028 2309  
Median age (range)‡
started drug use, in years 15 (12-22) 15 (12-22) 15 (11-22) 15 (12-22) 15 (11-22)  
Median age (range)‡
started injecting, in years 19 (15-27) 18 (14-28) 19 (14-30) 20 (15-34) 19 (15-28)   
Number (%) ever injected 148 (19.3) 181 (18.0) 237 (14.8) 311 (15.3) 342 (14.8)  
Of whom:§
‘ever shared’  66 (44.6) 62 (34.3) 101 (42.6) 139 (44.7) 142 (41.5)   
‘currently injecting’ 44 (29.7) 59 (32.6) 88 (37.1) 139 (44.7) 143 (41.8)   
‘currently sharing’   14 (9.5) 7 (3.9) 20 (8.4) 31 (10.0) 19 (5.6)   
Previously treated cases 
injector status known 275 416 593 760 891  
Median age (range)‡
started drug use, in years 15 (11-22) 15 (12-23) 15 (11-22) 15 (12-21) 15 (11-23)  
Median age (range)‡
started injecting, in years 20 (14-32) 19 (14-27) 19 (14-29) 20 (15-34) 20 (15-29)   
Number (%) ever injected 69 (25.1) 123 (29.6) 147 (24.8) 201 (26.4) 204 (22.9)  
Of whom:§
‘ever shared’  32 (46.4) 47 (38.2) 67 (45.6) 109 (54.2) 104 (51.0)  
‘currently injecting’   20 (29.0) 39 (31.7) 49 (33.3) 81 (40.3) 67 (32.8)  
‘currently sharing’   7 (10.1) 4 (3.3) 12 (8.2) 22 (10.9) 13 (6.4)   
New cases injector status known 439 574 985 1182 1299  
Median‡ age (range)‡
started drug use, in years 15 (12-21) 15 (11-21) 15 (12-22) 15 (12-22) 15 (11-22)  
Median age (range)‡
started injecting, in years 17 (15-26) 18 (14-29) 20 (14-30) 21 (15-35) 20 (15-29)   
Number (%) ever injected 52 (11.8) 52 (9.1) 80 (8.1) 87 (7.4) 101 (7.8) 
Of whom:§
‘ever shared’  18 (34.6) 14 (26.9) 30 (37.5) 27 (31.0) 35 (34.7)   
‘currently injecting’   9 (17.3) 18 (34.6) 34 (42.5) 40 (46.0) 51 (50.5)   
‘currently sharing’   3 (5.8) 2 (3.8) 8 (10.0) 9 (10.3) 6 (5.9)   
* Numbers include cases living in the Eastern Regional Health Authority but treated in another health board area, and exclude cases living in
one of the seven health board areas but treated in the Eastern Regional Health Authority and recorded in the NDTRS.
† Midland Health Board, Mid-Western Health Board, North Eastern Health Board, North Western Health Board, Southern Health Board, South
Eastern Health Board and Western Health Board. 
‡ Age range presented is the 5th to 95th percentile (90% of all cases age are within this range).
§ From the data presented in this table, it is not possible to ascertain the exact percentage of injectors with each risk factor of interest
because not all declared injectors were asked the subsequent injecting questions. 
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Socio-demographic characteristics
The median age of previously treated cases attending drug treatment services in the seven health boards
increased by two years in the period under review. The median age of new cases showed no particular trend
but was lower than the median age of previously treated cases between 1998 and 2002 (Table 8). The
proportion of cases less than 18 years of age increased by four per cent over the reporting period. As expected,
the proportion of cases less than 18 years of age was much higher among new cases than among those
previously treated. Overall, 79 per cent of cases who attended drug treatment services were male. From 1998
to 2002, there was a marginal increase in the proportion of male cases treated for problem drug use.  From
2000 to 2002, the proportion of previously treated cases who lived with their parents or family decreased,
while the proportion of new cases who lived with parents or family remained similar. The proportion of new
and previously treated cases reporting that they were homeless decreased between 1999 and 2002. Overall, 19
per cent of cases left school early during the period under review. The proportions were marginally higher
among previously treated cases when compared to new cases. It is clear that early school leavers are over-
represented among those seeking treatment for problem drug use but the direct relationship is unclear. From
1999 to 2002, the proportion reporting that they were employed followed national trends, with rates
increasing up to 2001 and decreasing by just over three per cent in 2002. Of note, employment rates were
higher among new cases compared to their previously treated counterparts, indicating that those with chronic
drug problems may be less likely to find or retain employment. This emphasises the importance of close
linkages between treatment interventions and social, educational and occupational reintegration programmes. 
Table 8   Socio-demographic characteristics of cases* treated in the seven health board† areas by
treatment status and reported to the NDTRS, 1998 to 2002 
Characteristics‡ 1998 1999 2000 2001 2002         
All cases‡ 888 1063 1671 2098 2397  
Median age (range)§ in years 21.7 (16.6-39.1) 22.0 (16.4-38.3) 22.2 (16.0-39.8) 22.8 (15.9-40.9) 23.1 (15.7-42.0)  
Number (%) under 18 years of age 123 (14.0) 165 (15.6) 284 (17.0) 354 (16.9) 432 (18.2)  
Number (%) of males 666 (77.1) 817 (77.4) 1323 (79.6) 1624 (78.0) 1851 (79.7)  
Number (%) living with parents/family 485 (54.6) 675 (63.5) 1038 (62.1) 1216 (58.0) 1405 (58.6)  
Number (%) homeless ** 66 (6.2) 90 (5.4) 83 (4.2) 77 (3.4)  
Number (%) of early school leavers†† 80 (14.5) 138 (19.2) 248 (19.4) 328 (20.8) 308 (17.6)  
Number (%) still in school 58 (9.5) 76 (9.6) 143 (10.1) 186 (10.5) 293 (14.3)  
Number (%) aged 16 to 64 years employed 252 (30.1) 281 (28.1) 525 (34.0) 660 (34.2) 670 (30.9)   
Previously treated cases‡ 306 441 618 787 917  
Median age (range)§ in years 23.5 (16.9-41.5) 24.4 (17.3-43.9) 23.6 (16.8-41.3) 25.0 (17.1-42.2) 25.5 (16.8-46.6)  
Number (%) under 18 years of age 30 (9.8) 35 (8.0) 66 (10.7) 68 (8.7) 84 (9.2)  
Number (%) of males 225 (75.8) 326 (74.6) 478 (77.3) 599 (76.6) 694 (78.3)  
Number (%) living with parents/family 167 (54.6) 240 (54.4) 345 (55.8) 379 (48.2) 447 (48.7)  
Number (%) homeless ** 36 (8.2) 38 (6.1) 37 (5.0) 33 (3.9)  
Number (%) of early school leavers†† 34 (16.3) 58 (19.8) 98 (20.1) 144 (23.5) 142 (20.2)  
Number (%) still in school 14 (6.3) 9 (3.0) 27 (5.3) 27 (4.2) 51 (6.7)  
Number (%) aged 16 to 64 years employed 70 (23.5) 88 (20.8) 164 (28.2) 217 (29.0) 245 (28.5)   
New cases‡ 472 595 1013 1205 1341  
Median age (range)§ in years 20.8 (16.4-37.4) 20.9 (16.1-34.1) 21.3 (15.8-38.3) 21.2 (15.3-38.2) 21.3 (15.3-38.0)  
Number (%) under 18 years of age 80 (17.0) 125 (21.1) 215 (21.2) 279 (23.2) 342 (25.7)  
Number (%) of males 364 (78.1) 470 (79.3) 812 (80.6) 936 (78.4) 1043 (80.8)  
Number (%) living with parents/family 306 (64.8) 442 (70.9) 668 (65.9) 800 (66.4) 891 (66.4)  
Number (%) homeless ** 25 (4.2) 47 (4.6) 31 (2.6) 26 (2.0)  
Number (%) of early school leavers†† 44 (13.2) 75 (18.2) 143 (18.6) 164 (18.4) 150 (15.5)  
Number (%) still in school 35 (9.5) 66 (13.8) 113 (12.8) 157 (15.0) 239 (19.8)  
Number (%) aged 16 to 64 years employed 145 (32.5) 189 (34.2) 354 (38.1) 416 (38.2) 392 (33.0)   
* Numbers include cases living in the Eastern Regional Health Authority but treated in another health board area, and exclude cases living in
one of the seven health board areas but treated in the Eastern Regional Health Authority and recorded in the NDTRS.
† Midland Health Board, Mid-Western Health Board, North Eastern Health Board, North Western Health Board, Southern Health Board, South
Eastern Health Board and Western Health Board. 
‡ It is not possible to ascertain the percentage with each characteristic of interest from the total number because not all forms had
complete data. 
§  Age range presented is the 5th to 95th percentile (90% of all cases age are within this range).
** Data not available
†† Left school before the age of 15 years.
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Conclusions
The number of new and previously treated cases in the seven health board areas and reported to the NDTRS
trebled between 1998 and 2002. For each of the years under review, more than half of those treated were
being treated for the first time.  Both new and previously treated cases in the seven health board areas most
frequently reported that cannabis was their main problem drug between 1998 and 2002.  Opiate use was
common in the health board areas in close proximity to the Eastern Regional Health Authority area.  The wide
spectrum of problem drug types reported indicates that treatment services need to cater for a number of licit
and illicit drugs used rather than focusing on one or two drugs.  Alcohol and ecstasy are important second
drugs, and as such need to be addressed in treatment programmes.  Polydrug use remained a common
practice that needs to be addressed in a client’s treatment plan.  The number of cases who reported injecting
trebled and this suggests that the drug treatment services outside the ERHA require prevention, harm reduction
and treatment interventions to deal with blood-borne viruses (in particular HIV, hepatitis B, and hepatitis C) and
drug overdose (in particular opiate-related overdoses).  A sizeable number of cases in the seven health board
areas were under 18 years old and these require different approaches to treatment; it is important that this is
recognised in service planning.  The low levels of educational achievement and employment among chronic
problem drug users emphasises the importance of close links between treatment interventions and social,
educational and occupational reintegration programmes. 
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